Homocysteine and Hypertension in Diabetes: Does PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>γ</mml:mi></mml:math>  Have a Regulatory Role?

<table><i>Glomerular hypertrophy and collapse in diabetes were ameliorated by ciglitazone.</i> Histological kidney section were stained with Masson-Trichrome stain and visualized under dissecting microscope. Note that glomerular hypertrophy was observed at one week of alloxan (a single dose of 65 mg/kg body wt intraperitoneally) treatment. At 10 weeks glomerulus was collapsed. Ciglitazone treatment after 10 weeks of alloxan treatment reversed glomerular deformation towards normal (magnification, x200).</table>

PPAR Research

fig2

Figure 2

Figure 2: Homocysteine and Hypertension in Diabetes: Does PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>γ</mml:mi></mml:math>  Have a Regulatory Role? 

PPAR Research

Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?

Figure 2